tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Balaji Prasad, 23 are a SELL (12.37%), 18 are a HOLD (9.68%), 145 are a BUY (77.96%).
Analyst Balaji Prasad, currently employed at BARCLAYS, carries an average stock price target met ratio of 42.17% that have a potential upside of 23.02% achieved within 221 days.
Balaji Prasad’s has documented 381 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on JAZZ, Jazz Pharmaceuticals PLC at 27-Feb-2025.
Analyst best performing recommendations are on MNK (MALLINCKRODT PLC).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $123.52 was fulfilled within 1 day with a profit of $11.16 (9.93%) receiving and performance score of 99.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$10
$2.56 (34.41%)
$11
1 months 1 days ago
(30-Jan-2025)
11/24 (45.83%)
$2.54 (34.05%)
187
Buy
$10
$2.56 (34.41%)
$14
5 months 12 days ago
(19-Sep-2024)
0/3 (0%)
$1.82 (22.25%)
Sell
$3
$-4.44 (-59.68%)
$9
7 months 1 days ago
(02-Aug-2024)
11/14 (78.57%)
$-2.63 (-46.71%)
201
Hold
$7
$-0.44 (-5.91%)
7 months 6 days ago
(25-Jul-2024)
1/1 (100%)
$1.12 (19.05%)
53
Buy
$16
$8.56 (115.05%)
$9.5
1 years 5 months 11 days ago
(20-Sep-2023)
4/5 (80%)
$7.66 (91.85%)
143
Which stock is Balaji Prasad is most bullish on?
Which stock is Balaji Prasad is most reserved on?
What Year was the first public recommendation made by Balaji Prasad?
